Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Concept Phase II Study With the PDE4 Inhibitor Roflumilast in Patients With (Amnestic) Mild Cognitive Impairment (MCI) or Mild Dementia

NCT04658654 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT04658654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04658654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Concept Phase II Study With the PDE4 Inhibitor Roflumilast in Patients With (Amnestic) Mild Cognitive Impairment (MCI) or Mild Dementia
Lead sponsor
Maastricht University Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
November 19, 2021
Completion date
October 31, 2023
Enrollment
81 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amnestic mild cognitive disorder, mild cognitive impairment, mild dementia